Keyphrases
Multiple Sclerosis
100%
Tetraplex
56%
Israel
54%
Myelin Oligodendrocyte Glycoprotein
44%
Fragile X Syndrome
40%
Autoimmune Encephalitis
37%
Oligoclonal Bands
37%
Saliva
37%
Disease Monitoring
37%
Free Light Chains
37%
Clinical Features
37%
Attention Deficit Hyperactivity Disorder
37%
Multiple Sclerosis Treatment
36%
Pediatric multiple Sclerosis
36%
Clinical Presentation
35%
Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD)
31%
Myelin Oligodendrocyte Glycoprotein Antibody
29%
Disease Activity
29%
Cognitive Impairment
29%
Fragile X Mental Retardation 1 (FMR1)
26%
Seizure
24%
Disease Course
23%
Optic Neuritis
22%
Associated Diseases
22%
Autoimmune Disease
22%
Israeli
21%
Immunoglobulin Free Light Chains
21%
Delayed Diagnosis
20%
Disease-modifying Therapy
20%
COVID-19 Impact
18%
Migraine
18%
Body Mass Index
18%
COVID-19 Vaccination
18%
Unveiling
18%
Maternal Alcohol Consumption
18%
Coping Flexibility
18%
Expert Group
18%
Israeli children
18%
Cladribine
18%
Well-being
18%
Clinical Profile
18%
GFAP Astrocytopathy
18%
Late Diagnosis
18%
Image Features
18%
Autoantibodies
18%
Paraneoplastic Syndrome
18%
Long-term Survival
18%
Age-related
18%
Response to Treatment
18%
Seropositivity
18%
Medicine and Dentistry
Diseases
75%
Multiple Sclerosis
71%
Magnetic Resonance Imaging
70%
Myelin Oligodendrocyte Glycoprotein
37%
Pediatrics
33%
Cerebrospinal Fluid
21%
Oligoclonal Band
18%
Light Chain
18%
Alcohol Consumption
18%
Allergic Encephalitis
18%
COVID-19 Vaccination
18%
Paraneoplastic Syndrome
18%
Paraneoplastic Cerebellar Degeneration
18%
Long Term Survival
18%
Disease Course
18%
Attention Deficit Disorder
18%
Combination Therapy
18%
Patient with Attention Deficit Hyperactivity Disorder
18%
Pediatrics Patient
18%
Treatment Response
18%
Clinically Isolated Syndrome
17%
Encephalitis
12%
Expanded Disability Status Scale
11%
Rituximab
10%
Malignant Neoplasm
10%
Prognostic Factor
9%
Recurrence Risk
9%
Plasmapheresis
7%
Recurrent Disease
7%
Corpus Callosum
7%
Pleocytosis
7%
Epileptic Seizure
6%
Disease Activity
6%
Neurologic Finding
6%
N-Methyl-D-Aspartic Acid
6%
Behavioral Change
6%
Neurodevelopmental Disorder
6%
Sleep Quality
6%
Sleep Disorder
6%
Disease
5%
Neuroscience
Multiple Sclerosis
75%
Myelin Oligodendrocyte Glycoprotein
56%
Magnetic Resonance Imaging
52%
Attention Deficit Hyperactivity Disorder
39%
Encephalitis
37%
Oligoclonal Band
37%
Light Chain
37%
Intravenous Immunoglobulin
32%
Autoimmune Disease
20%
Expanded Disability Status Scale
19%
Benign Epilepsy
18%
Cognitive Disorders
18%
Body Mass Index
18%
Demyelinating Disease
18%
Migraine
18%
Autoantibodies
18%
Narcolepsy
18%
Optic Neuritis
15%
Rituximab
11%
Orexin
10%
Demyelinating Disorder
9%
N Methyl Dextro Aspartic Acid Receptor Antibody
9%
Sleep Disorder
8%
Acute Disseminated Encephalomyelitis
7%
Corpus Callosum
7%
Azathioprine
7%
Mycophenolate Mofetil
7%
Monomer
6%
Meningitis
6%
Caudate Nucleus
6%
Pons
6%
Myelitis
6%
Transverse Myelitis
6%
Brainstem
6%
MOG Antibody Disease
6%
Acid Protein
6%
N-Methyl-D-Aspartic Acid
6%
Neuromyelitis Optica
5%
Sleep Quality
5%